FDA Inspection 972661 — Nuvisan GmbH

Nuvisan GmbH — FEI 3003046251

The FDA completed an inspection of Nuvisan GmbH on Apr 26, 2016 in Waltrop. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 26, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Waltrop (Germany)

Citations

IDCFRDescription
126321 CFR 211.68(b)Computer control of master formula records
200821 CFR 211.186(a)Written procedures followed
360321 CFR 211.160(b)Scientifically sound laboratory controls

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.